Nucleome
A senior scientific leader driving antibody discovery and biologics capabilities at Nucleome Therapeutics to expand the therapeutic pipeline. Reporting to the CSO, this role establishes engineering strategies, guides programmes from target validation to candidate selection, and oversees external partnerships for high-quality delivery. The position involves shaping discovery strategy, mentoring internal teams, and providing data-driven recommendations to support portfolio prioritization.
Headquarters
Oxford, England, United Kingdom
Company Size
11-50 employees
Founded
2019
Nucleome is a biotech company focused on unlocking the non‑coding human genome to discover mechanisms and therapeutic targets for inflammatory diseases. Using a platform that combines large‑scale genomics, epigenomics, single‑cell profiling and functional perturbations, they map regulatory elements and link non‑coding variation to disease biology. The company translates those insights into target prioritization and partnerships with drug developers to advance new precision therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nucleome.
18% above the average for this role
Senior Scientist/Scientist, Antibody Engineering & Biologics
ASTARPRD
Senior Scientist, Molecular Discovery
MSD
Antibody Drug Discovery Lead
C0003153479P
Senior Scientist, Antibody Discovery & Data Science
AstraZeneca
Senior Analyst – Antibody Discovery
Elanco
Scientist – Antibody Discovery/Protein Engineering
Eurofins